Skip to main content
SpringerLink
Log in

Particular Antiepileptic Drugs and Foetal Malformations

  • Chapter
Antiepileptic Drugs and Pregnancy

Abstract

This chapter attempts to discuss the published information concerning the risks of structural malformations occurring in foetuses exposed to those individual antiepileptic drugs that have been widely enough used in women with epilepsy for relevant data to be available. There appears to be persuasive evidence that valproate is a dose-related teratogen, with certain malformations such as neural tube defects seeming to be particularly associated with high maternal dosage of the drug. Evidence also points towards topiramate being a dose-related teratogen. On the basis of the available data the possibility that the remaining currently used drugs are teratogens cannot be excluded, but there appears to be enough evidence to indicate that any teratogenic hazard arising from exposure to them is quite small.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akar M, Dilli D, Yilmaz Y, Erdeve O, Oyuz S, Uras N, Dilmen U (2012) A case of fetal carbamazepine syndrome with right hemihypoplasia of the entire body. Genet Couns 23:19–24

    CAS  PubMed  Google Scholar 

  • Andermann E, Dansky L, Andermann F, Loughnan PM, Gibbons J (1982) Minor congenital malformations and dermatoglyphic alterations in the offspring of epileptic women: a clinical investigation of the teratogenic effect of anticonvulsant medication. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D (eds) Epilepsy, pregnancy and the child. Raven, New York, pp 235–249

    Google Scholar 

  • Arpino C, Bresarini S, Robert W et al (2000) Teratogenic effects of antiepileptic drugs: use of an international database on malformation and drug exposure (MADRE). Epilepsia 41:1436–1443

    Article  CAS  PubMed  Google Scholar 

  • Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J (2005) Antiepileptic drug use of women with epilepsy and congenital malformations in the offspring. Neurology 64:1874–1878

    Article  CAS  PubMed  Google Scholar 

  • Bailey CJ, Pool RW, Poskitt EME, Harris F (1983) Valproic abnormality and fetal abnormality. Br Med J 286:190

    Article  CAS  Google Scholar 

  • Barr MJ, Pozanski AK, Schmickel RD (1974) Digital hypoplasia and anticonvulsants during gestation; a teratogenic syndrome? J Pediatr 84:254–257

    Article  PubMed  Google Scholar 

  • Bjerkedal T, Czeizel A, Goujard J et al (1982) Valproic acid and spina bifida. Lancet 2:1096

    Article  CAS  PubMed  Google Scholar 

  • Bonnot O, Vollset SE, Godet PF, d’Amato T, Dalery J, Robert E (2003) In utero exposure to benzodiazepine: is there a risk for anal atresia with lorazepam? Encéphale 29:553–559

    CAS  PubMed  Google Scholar 

  • Bromfield EB, Dworetzky BA, Wyszynski DF, Smith CR, Baldwin EJ, Holmes LB (2008) Valproate teratogenicity and epilepsy syndromes. Epilepsia 49:2122–2124

    Article  CAS  PubMed  Google Scholar 

  • Campbell E, Kennedy F, Russell A et al (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 85:1029–1034

    Article  CAS  PubMed  Google Scholar 

  • Canger R, Battino D, Canevini MP et al (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:1231–1236

    Article  CAS  PubMed  Google Scholar 

  • Chaudhry SA, Jong G, Koren G (2014) The fetal safety of levetiracetam. Reprod Toxicol 46C:40–45

    Article  Google Scholar 

  • Cunnington M, Ferber S, Quartey G, International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2007) Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 48:1207–1210

    Article  CAS  PubMed  Google Scholar 

  • Curran MAW (1987) The management of epilepsy in women of child-bearing age and the Australian experience of valproate in pregnancy. Clin Exp Neurol 23:145–148

    CAS  PubMed  Google Scholar 

  • Danks DM, Barry JE, Sheffield LJ (1974) Digital hypoplasia and anticonvulsants during pregnancy. J Pediatr 85:877

    Article  CAS  PubMed  Google Scholar 

  • Di Liberti JH, Farndon RA, Dennis NR, Curry CJR (1984) The fetal valproate syndrome. Am J Med Genet 19:473–481

    Article  Google Scholar 

  • Diav-Citrin O, Shectman S, Arnon J, Ornoy A (2001) Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology 57:321–324

    Article  CAS  PubMed  Google Scholar 

  • Diav-Cirtin O, Shechhman S, Bar-Oz, Cantrell D, Amon J, Ornoy A (2008) Pregtnancy outcome after in utero exposure to valproate - evidence of dose relationship in teratogenic effect. CNS Drugs 22: 325–335

    Google Scholar 

  • Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case–control studies. Br Med J 317:839–843

    Article  CAS  Google Scholar 

  • Dravet C, Julian C, Legras C et al (1992) Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 42(Suppl 5):75–82

    CAS  PubMed  Google Scholar 

  • Eadie MJ (2008) Antiepileptic drugs as human teratogens. Expert Opin Drug Saf 7:195–201

    Article  CAS  PubMed  Google Scholar 

  • Enato E, Moretti M, Koren G (2011) The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can 33:46–48

    PubMed  Google Scholar 

  • Fujii H, Goel A, Bernard N et al (2013) Pregnancy outcomes following gabapentin use. Results of a prospective comparative study. Neurology 80:1565–1570

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hanson JW, Smith DW (1975) The fetal hydantoin syndrome. J Pediatr 87:285–290

    Article  CAS  PubMed  Google Scholar 

  • Hernandez-Diaz S, Smith CR, Wyzszynski D (2007) Risk of major malformations among infants exposed to carbamazepine during pregnancy. Proc 47th Teratol Soc Meet Birth Defects Res (Part A) 79:357 (Cited by Wlodarczyl 2012, loc cit)

    Google Scholar 

  • Hernandez-Diaz S, Smith CR, Shen A et al (2012) Comparative study of antiepileptic drugs during pregnancy. Neurology 78:1692–1699

    Article  CAS  PubMed  Google Scholar 

  • Hill RM, Verniaud WM, Horning MD, McCulley LB, Morgan NF (1974) Infants exposed in utero to antiepileptic drugs. Am J Dis Child 127:645–653

    Article  CAS  PubMed  Google Scholar 

  • Holmes LB, Hernandez-Diaz S (2012) Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res (Part A) 94:599–606

    Article  CAS  Google Scholar 

  • Holmes LB, Wyszynski DF, Lieberman E, for the AED Pregnancy Registry (2004) The AED (antiepileptic drug) pregnancy registry. A 6-year experience. Arch Neurol 61:673–678

    Article  PubMed  Google Scholar 

  • Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, Wyuszynski DF (2008) Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70:2152–2158

    Article  CAS  PubMed  Google Scholar 

  • Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S (2011) Fetal effects of anticonvulsant polytherapies. Arch Neurol 68:1275–1281

    Article  PubMed  Google Scholar 

  • Hunt S, Russell A, Smithson WH et al (2008) Topiramate in pregnancy. Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 71:272–276

    Article  CAS  PubMed  Google Scholar 

  • Jacobsen PE, Henriksen TB, Haubek D, Østergaard JR (2014) Prenatal exposure to antiepileptic drugs and dental agenesis. PLoS One 9, e84420

    Article  PubMed Central  PubMed  Google Scholar 

  • Jager-Roman E, Deichl A, Jakob S (1986) Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 108:997–1004

    Article  CAS  PubMed  Google Scholar 

  • Janz D, Fuchs U (1964) Are anti-epileptic drugs harmful when given during pregnancy? Ger Med Mont 9:20–22

    Google Scholar 

  • Jentink J, Dolk H, Loane MA, Wellesley D, Game E, de Jong-van den Berg L, EUROCAT Antiepileptic Study Group (2010) Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case–control study. Br Med J 341:c6581

    Article  Google Scholar 

  • Jones KL, Lacro RV, Johnson KA, Adams J (1989) Pattern of malformations in children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661–1666

    Article  CAS  PubMed  Google Scholar 

  • Kaaja E, Kaaja R, Hiilesmaa V (2003) Major malformations in offspring of women with epilepsy. Neurology 60:575–579

    Article  PubMed  Google Scholar 

  • Kallen AJ (1994) Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8:203–205

    Article  CAS  PubMed  Google Scholar 

  • Kallen B, Robert E, Mastroiacovo P, Martinez-Frias ML, Castilla EE, Cocchi G (1989) Anticonvulsant drugs and malformations is there a drug specificity? Eur J Epidemiol 5:31–36

    Article  CAS  PubMed  Google Scholar 

  • Kaneko S, Battino D, Andermann E et al (1999) Congenital malformations due to antiepileptic drugs. Epilepsy Res 33:145–158

    Article  CAS  PubMed  Google Scholar 

  • Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J, Liverpool and Manchester Neurodevelopmental Study Group (2006) Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Neonatal Ed 91:F90–F95

    Article  CAS  Google Scholar 

  • Kjaer D, Horvath-Puhó E, Christensen J, Vestergaard M, Czeizel AE, Sørensen HT, Olsen J (2007) Use of phenytoin, phenobarbital, or diazepam during pregnancy and the risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf 16:181–188

    Article  CAS  PubMed  Google Scholar 

  • Koch S, Losche G, Jager-Romän C, Jakob S, Rating D, Deichl A, Helge H (1992) Major and minor birth malformations and antiepileptic drugs. Neurology 42(4 Suppl 5):83–88

    CAS  PubMed  Google Scholar 

  • Kondo T, Kaneko S, Amano Y, Egawa I (1996) Preliminary report of teratogenic effect of zonisamide in the offspring of treated women with epilepsy. Epilepsia 37:1242–1244

    Article  CAS  PubMed  Google Scholar 

  • Kozma C (2001) Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet (Part A) 98:168–175

    Article  CAS  Google Scholar 

  • Lin AE, Peller AJ, Westgate M-N, Houda K, Franz A, Holmes LB (2004) Clonazepam use in pregnancy and the risk of malformation. Birth Defects Res (Part A) 70:534–536

    Article  CAS  Google Scholar 

  • Lindhout D, Meinardi H (1984) Spina bifida and in utero exposure to valproate. Lancet 2:396

    Article  CAS  PubMed  Google Scholar 

  • Lindhout D, Omtzigt JG (1992) Pregnancy and the risk of teratogenicity. Epilepsia 33(Suppl 4):S41–S48

    Article  PubMed  Google Scholar 

  • Lindhout D, Schmidt D (1986) In-utero exposure to valproate and neural-tube defects. Lancet 2:1392–1393

    Article  Google Scholar 

  • Little BB, Santos-Ramos R, Newell JF, Mayberry MC (1993) Megadose carbamazepine during the period of neural tube closure. Obstet Gynecol 82:705–708

    CAS  PubMed  Google Scholar 

  • Loughnan PM, Gold H, Vance JC (1973) Phenytoin teratogenicity in man. Lancet 1:70–72

    Article  CAS  PubMed  Google Scholar 

  • Lype M, Henry P, Aravind C, Arun K (2008) Baller-Gerold syndrome: further evidence for association with prenatal exposure to valproate. Ann Indian Acad Neurol 11:52–55

    Article  PubMed Central  PubMed  Google Scholar 

  • Mahwinney E, Craig J, Morrow J et al (2013) Levetiracetam in pregnancy. Results from the UK and Ireland epilepsy and pregnancy registers. Neurology 80:401–405

    Google Scholar 

  • Marguilis AV, Mitchell AA, Gilboa SM et al (2012) Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 207:405 e1–e7

    Google Scholar 

  • Matalon S, Schectman S, Goldzweig G, Ornoy A (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16:9–17

    Article  CAS  PubMed  Google Scholar 

  • Mawer G, Briggs M, Baker GA et al (2010) Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 19:112–119

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • McElhatton PR (1994) The effect of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 8:461–475

    Article  CAS  PubMed  Google Scholar 

  • McMahon CL, Braddock SR (2001) Septo-optic dysplasia as a manifestation of valproic acid embryopathy. Teratology 64:83–86

    Article  CAS  PubMed  Google Scholar 

  • Meador KJ, Baker JA, Finnell RH et al (2006) In utero fetal drug exposure. Fetal death and malformations. Neurology 67:407–412

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C (2008) Pregnancy outcomes in women with epilepsy: a systematic review and analysis of published pregnancy registers and cohorts. Epilepsy Res 81:1–13

    Article  PubMed Central  PubMed  Google Scholar 

  • Meischenguiser R, D’Giano CH, Ferraro SM (2004) Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 5:163–167

    Article  PubMed  Google Scholar 

  • Miki T, Reo T, Tohru K, Joseph B, Gideon K, Elizabeth U, Shinya I (2014) Risks of congenital malformations in offspring exposed to valproic acid in utero: Emergence of the signals over the last 30 years. J Popul Ther Clin Pharmacol 21:2 (e277)

    Google Scholar 

  • Mines D, Tennis P, Curkendall SM et al (2014) Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf 23:1017–1025

    Article  CAS  PubMed  Google Scholar 

  • Molgaard-Nielsen D, Hviid A (2011) Newer-generation antiepileptic drugs and the risk of major birth defects. J Am Med Assoc 305:1996–2002

    Article  Google Scholar 

  • Monson RR, Rosenberg L, Hartz SC, Shapiro S, Heinonen OP, Stone D (1973) Diphenylhydantoin and selected congenital malformations. N Engl J Med 289:1049–1052

    Article  CAS  PubMed  Google Scholar 

  • Montouris G (2003) Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4:310–317

    Article  PubMed  Google Scholar 

  • Montouris G (2005) Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 21:693–701

    Article  CAS  PubMed  Google Scholar 

  • Moore SJ, Turpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, Dean JC (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 37:489–497

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Morrow J, Russell A, Guthrie E et al (2006) Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193–198

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nelson MM, Forfar IO (1971) Association between drugs administered during pregnancy and congenital abnormalities in the fetus. Br Med J 1:523–527

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Omtzigt JG, Los FJ, Grobbee DE et al (1992) The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort. Neurology 42(Suppl 5):119–125

    CAS  PubMed  Google Scholar 

  • Ornoy A, Cohen E (1996) Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 75:517–520

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ornoy A, Zvi N, Arnon J, Waajnberg R, Schectman S, Diav-Citrin O (2008) The outcome of pregnancy following topiramate treatment: a study of 52 pregnancies. Reprod Toxicol 25:388–389

    Article  CAS  PubMed  Google Scholar 

  • Phelan MC, Pellock JM, Nance WE (1982) Discordant expression of the fetal hydantoin syndrome in heteropaternal dizygotic twins. N Engl J Med 307:99–101

    Article  CAS  PubMed  Google Scholar 

  • Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet 2:937

    Article  CAS  PubMed  Google Scholar 

  • Robert E, Rosa F (1983) Valproate and birth defects. Lancet 2:1142

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg L, Mitchall AA, Parsells JL, Pashayan H, Louik C, Shapiro S (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309:1282–1285

    Article  CAS  PubMed  Google Scholar 

  • Sabers A, Dam M, a-Rogvi-Hansen B et al (2004) Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand 109:9–13

    Article  CAS  PubMed  Google Scholar 

  • Safra MJ, Oakey GPJ (1975) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2:478–480

    Article  CAS  PubMed  Google Scholar 

  • Samrén EB, van Duijn CM, Koch S et al (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38:981–990

    Article  PubMed  Google Scholar 

  • Samrén EB, van Duijn CM, Lieve Christiaens GCM, Hofman A, Lindhout D (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739–746

    Article  PubMed  Google Scholar 

  • Shapiro S, Hartz SC, Siskind V et al (1976) Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1:272–275

    Article  CAS  PubMed  Google Scholar 

  • Speidel BD, Meadow SR (1972) Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 2:839–843

    Article  CAS  PubMed  Google Scholar 

  • Staples RE (1972) Teratology. In: Penry JK, Schmidt RP, Woodbury DM (eds) Antiepileptic drugs. Raven, New York, pp 55–62

    Google Scholar 

  • Starreveld-Zimmerman AAE, Van Der Kolk WJ, Meinardi H, Elshove J (1973) Are anticonvulsants teratogenic? Lancet 2:48–49

    Article  CAS  PubMed  Google Scholar 

  • Tomson T, Battino D, Bonizzoni E et al (2011) Dose-dependent risk of malformation with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10:609–617

    Article  CAS  PubMed  Google Scholar 

  • Vajda FJE, Eadie MJ (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112:137–143

    Article  CAS  PubMed  Google Scholar 

  • Vajda FJ, O’Brien TJ, Hitchcock A, Graham J, Cook M, Lander C, Eadie MJ (2004) Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 11:854–858

    Article  CAS  PubMed  Google Scholar 

  • Vajda F, Hitchcock A, Graham J, Solinas C, O’Brien TJ, Lander CM, Eadie MJ (2006) Foetal malformations and seizure control: 52 months data of the Register, Australian Pregnancy. Eur J Neurol 13:645–654

    Article  CAS  PubMed  Google Scholar 

  • Vajda FJE, Graham J, Hitchock AA, O’Brien TJ, Lander CM, Eadie MJ (2010) Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 19:555–561

    Article  Google Scholar 

  • Vajda FJE, O’Brien TJ, Graham J, Lander CM, Eadie MJ (2013a) Associations between particular types of fetal malformation and antiepileptic drug exposure. Acta Neurol Scand 128:228–234

    Article  CAS  PubMed  Google Scholar 

  • Vajda FJE, O’Brien TJ, Graham J, Lander CM, Eadie MJ (2013b) Dose-dependency of fetal malformations associated with valproate. Neurology 81:999–1003

    Article  CAS  PubMed  Google Scholar 

  • Vajda FJE, O’Brien TJ, Lander CM, Graham J, Eadie MJ (2014) The teratogenicity of the newer antiepileptic drugs – an update. Ácta Neurol Scand 130: 234–238

    Google Scholar 

  • Veiby G, Daltveit AK, Engelsen BA, Gilhus NE (2014) Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol 261:579–588

    Article  CAS  PubMed  Google Scholar 

  • Wheatley D (1963) Drugs in pregnancy survey. Practitioner 191:775–780

    Google Scholar 

  • Wlodarczyk BJ, Palacios AM, George TM, Finnell TH (2012) Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A 158A:2071–2090

    Article  PubMed Central  PubMed  Google Scholar 

  • Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB, Antiepileptic Drug Pregnancy Registry (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64:961–965

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Neurology and Neuropharmacology, University of Queensland, and Honorary Consultant Neurologist, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia

    MJ Eadie (Emeritus Professor)

  2. Department of Medicine and Neurology Director of the Australian Epilepsy and Pregnancy Register, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia

    FJE Vajda

Authors
  1. MJ Eadie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. FJE Vajda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Eadie, M., Vajda, F. (2016). Particular Antiepileptic Drugs and Foetal Malformations. In: Antiepileptic Drugs and Pregnancy. Adis, Cham. https://doi.org/10.1007/978-3-319-21434-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21434-4_9

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-21433-7

  • Online ISBN: 978-3-319-21434-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation